Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators.

Lancet Neurol. 2019 Sep;18(9):845-856. doi: 10.1016/S1474-4422(19)30137-1. Epub 2019 Jul 5.

PMID:
31285147
2.

Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.

Vidmar L, Maver A, Drulović J, Sepčić J, Novaković I, Ristič S, Šega S, Peterlin B.

Sci Rep. 2019 Jun 24;9(1):9171. doi: 10.1038/s41598-019-45598-x.

3.

Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder.

Savoldi F, Rocca MA, Valsasina P, Riccitelli GC, Mesaros S, Drulovic J, Radaelli M, Filippi M.

Mult Scler. 2019 May 13:1352458519845109. doi: 10.1177/1352458519845109. [Epub ahead of print]

PMID:
31079538
4.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
5.

Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study.

Drulovic J, Ivanovic J, Mesaros S, Martinovic V, Kisic-Tepavcevic D, Dujmovic I, Pekmezovic T.

Neurol Sci. 2019 Aug;40(8):1627-1636. doi: 10.1007/s10072-019-03878-4. Epub 2019 Apr 22.

PMID:
31011930
6.

Longitudinally extensive transverse myelitis in a patient infected with West Nile virus.

Martinovic V, Kisic-Tepavcevic D, Kacar A, Mesaros S, Pekmezovic T, Drulovic J.

Mult Scler Relat Disord. 2019 Jul;32:19-22. doi: 10.1016/j.msard.2019.04.007. Epub 2019 Apr 16.

PMID:
31005826
7.

Two-year dynamic functional network connectivity in clinically isolated syndrome.

Rocca MA, Hidalgo de La Cruz M, Valsasina P, Mesaros S, Martinovic V, Ivanovic J, Drulovic J, Filippi M.

Mult Scler. 2019 Mar 19:1352458519837704. doi: 10.1177/1352458519837704. [Epub ahead of print]

PMID:
30887875
8.

Autonomic dysfunction in people with neuromyelitis optica spectrum disorders.

Crnošija L, Krbot Skorić M, Andabaka M, Junaković A, Martinović V, Ivanović J, Mesaroš Š, Pekmezović T, Drulović J, Habek M.

Mult Scler. 2019 Mar 19:1352458519837703. doi: 10.1177/1352458519837703. [Epub ahead of print]

PMID:
30887872
9.

Brain and cord imaging features in neuromyelitis optica spectrum disorders.

Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, Pagani E, Martinelli V, Matthews L, Drulovic J, Leite MI, Comi G, Filippi M, Rocca MA.

Ann Neurol. 2019 Mar;85(3):371-384. doi: 10.1002/ana.25411. Epub 2019 Jan 28.

PMID:
30635936
10.

Bilateral horizontal gaze palsy in benign multiple sclerosis.

Martinovic V, Nikolic I, Mesaros S, Drulovic J.

Acta Neurol Belg. 2018 Dec 17. doi: 10.1007/s13760-018-01064-5. [Epub ahead of print] No abstract available.

PMID:
30560418
11.

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.

Giordano A, Liethmann K, Köpke S, Poettgen J, Rahn AC, Drulovic J, Beckmann Y, Sastre-Garriga J, Galea I, Heerings M, Jongen PJ, Vettorazzi E, Solari A, Heesen C; AutoMS group.

PLoS One. 2018 Nov 29;13(11):e0208004. doi: 10.1371/journal.pone.0208004. eCollection 2018.

12.

Multiple sclerosis registries in Europe - An updated mapping survey.

Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C.

Mult Scler Relat Disord. 2019 Jan;27:171-178. doi: 10.1016/j.msard.2018.09.032. Epub 2018 Oct 4. No abstract available.

PMID:
30384204
13.

International consensus on quality standards for brain health-focused care in multiple sclerosis.

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G.

Mult Scler. 2018 Nov 1:1352458518809326. doi: 10.1177/1352458518809326. [Epub ahead of print]

PMID:
30381987
14.

Successful treatment of paraneoplastic longitudinally extensive transverse myelitis (LETM): A 16-month clinical-spinal MRI follow-up.

Ivanovic J, Mesaros S, Drulovic J.

Mult Scler Relat Disord. 2018 Nov;26:207-210. doi: 10.1016/j.msard.2018.09.023. Epub 2018 Sep 22.

PMID:
30268997
15.

Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Krbot Skorić M, Crnošija L, Adamec I, Barun B, Gabelić T, Smoljo T, Stanić I, Pavičić T, Pavlović I, Drulović J, Pekmezović T, Habek M.

Clin Auton Res. 2019 Jun;29(3):321-328. doi: 10.1007/s10286-018-0563-6. Epub 2018 Sep 12.

PMID:
30209702
16.

Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: A 2-year MRI study.

Cacciaguerra L, Pagani E, Mesaros S, Dackovic J, Dujmovic-Basuroski I, Drulovic J, Valsasina P, Filippi M, Rocca MA.

Mult Scler. 2019 Aug;25(9):1232-1242. doi: 10.1177/1352458518787347. Epub 2018 Jul 24.

PMID:
30039746
17.

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.

Köpke S, Giordano A, Veronese S, Christin Rahn A, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, Patti F, Pekmezovic T, Sastre-Garriga J, Vosburgh J, Voltz R, Bay J, Oliver DJ, Solari A.

Eur J Neurol. 2019 Jan;26(1):41-50. doi: 10.1111/ene.13760. Epub 2018 Sep 9.

PMID:
30035845
18.

Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.

Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.

Mult Scler. 2018 Jul 1:1352458518786055. doi: 10.1177/1352458518786055. [Epub ahead of print]

PMID:
29985092
19.

Autophagy-independent increase of ATG5 expression in T cells of multiple sclerosis patients.

Paunovic V, Petrovic IV, Milenkovic M, Janjetovic K, Pravica V, Dujmovic I, Milosevic E, Martinovic V, Mesaros S, Drulovic J, Trajkovic V.

J Neuroimmunol. 2018 Jun 15;319:100-105. doi: 10.1016/j.jneuroim.2018.03.001. Epub 2018 Mar 5.

PMID:
29548704
20.

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.

Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M.

Brain. 2018 Apr 1;141(4):1085-1093. doi: 10.1093/brain/awy021.

PMID:
29452342
21.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
22.

Heroin-induced acute longitudinally extensive transverse myelopathy.

Dujmovic I, Nikolic I, Martinovic V, Mesaros S, Drulovic J.

Neurol Sci. 2018 Apr;39(4):791-792. doi: 10.1007/s10072-017-3197-x. Epub 2017 Nov 17. No abstract available.

PMID:
29149398
23.

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).

Heesen C, Pöttgen J, Rahn AC, Liethmann K, Kasper J, Vahter L, Drulovic J, Van Nunen A, Wilkie D, Beckmann Y, Paul F, Köpke S, Giordano A, Solari A; AutoMS-group.

Mult Scler Relat Disord. 2017 Nov;18:186-195. doi: 10.1016/j.msard.2017.09.020. Epub 2017 Sep 21.

PMID:
29141808
24.

Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis.

Drulović J, Gavrilović A, Crnošija L, Kisić-Tepavčević D, Krbot Skorić M, Ivanović J, Adamec I, Dujmović I, Junaković A, Marić G, Martinović V, Pekmezović T, Habek M.

Croat Med J. 2017 Oct 31;58(5):342-348.

25.

Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?

Mader S, Jeganathan V, Arinuma Y, Fujieda Y, Dujmovic I, Drulovic J, Shimizu Y, Sakuma Y, Stern JNH, Aranow C, Mackay M, Yasuda S, Atsumi T, Hirohata S, Diamond B.

Arthritis Rheumatol. 2018 Feb;70(2):277-286. doi: 10.1002/art.40356. Epub 2018 Jan 9.

26.

Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.

Preziosa P, Pagani E, Mesaros S, Riccitelli GC, Dackovic J, Drulovic J, Filippi M, Rocca MA.

Hum Brain Mapp. 2017 Nov;38(11):5648-5665. doi: 10.1002/hbm.23755. Epub 2017 Aug 9.

PMID:
28792103
27.

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria.

Preziosa P, Rocca MA, Mesaros S, Meani A, Montalban X, Drulovic J, Droby A, Zipp F, Calabrese M, Sastre-Garriga J, Dujmovic-Basuroski I, Rovira A, Filippi M.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):316-318. doi: 10.1136/jnnp-2017-315863. Epub 2017 Jul 19. No abstract available.

PMID:
28724720
28.

Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis.

Maver A, Lavtar P, Ristić S, Stopinšek S, Simčič S, Hočevar K, Sepčić J, Drulović J, Pekmezović T, Novaković I, Alenka H, Rudolf G, Šega S, Starčević-Čizmarević N, Palandačić A, Zamolo G, Kapović M, Likar T, Peterlin B.

Sci Rep. 2017 Jun 16;7(1):3715. doi: 10.1038/s41598-017-03536-9.

29.

Gait pattern in patients with different multiple sclerosis phenotypes.

Dujmovic I, Radovanovic S, Martinovic V, Dackovic J, Maric G, Mesaros S, Pekmezovic T, Kostic V, Drulovic J.

Mult Scler Relat Disord. 2017 Apr;13:13-20. doi: 10.1016/j.msard.2017.01.012. Epub 2017 Jan 26.

PMID:
28427694
30.

Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2.

Rakocevic-Stojanovic V, Peric S, Dujmovic I, Drulovic J, Pesovic J, Savic-Pavicevic D.

J Neuromuscul Dis. 2017;4(1):89-92. doi: 10.3233/JND-160192.

PMID:
28106565
31.

The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.

Drulovic J, Cukic M, Grgic S, Dincic E, Raicevic R, Nadj C, Toncev G, Vojinovic S, Mesaros S, Kisic Tepavcevic D, Dujmovic I, Tadic D, Miletic-Drakulic S, Dackovic J, Kostic S, Erakovic J, Sakalas L, Savic D, Suknjaja V, Martinovic V, Maric G, Pekmezovic T.

Mult Scler Relat Disord. 2017 Jan;11:56-61. doi: 10.1016/j.msard.2016.12.002. Epub 2016 Dec 8.

PMID:
28104258
32.

Bladder dysfunction in multiple sclerosis: a 6-year follow-up study.

Kisic Tepavcevic D, Pekmezovic T, Dujmovic Basuroski I, Mesaros S, Drulovic J.

Acta Neurol Belg. 2017 Mar;117(1):83-90. doi: 10.1007/s13760-016-0741-z. Epub 2017 Jan 13.

PMID:
28092018
33.

Corrigendum to "Sexual dysfunction in multiple sclerosis: A 6-year follow-up study" [J. Neurol. Sci. 358 (2015) 317-323].

Kisic-Tepavcevic D, Pekmezovic T, Trajkovic G, Stojsavljevic N, Dujmovic I, Mesaros S, Drulovic J.

J Neurol Sci. 2017 Jan 15;372:201. doi: 10.1016/j.jns.2016.11.020. Epub 2016 Nov 26. No abstract available.

PMID:
28017212
34.

Cross-cultural adaptation and validation of the disease specific questionnaire OQLQ in Serbian patients with malocclusions.

Vucic L, Glisic B, Kisic-Tepavcevic D, Vucic U, Drulovic J, Pekmezovic T.

Zdr Varst. 2016 May 10;55(3):166-173. eCollection 2016 Sep 1. Review.

35.

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.

Trentini A, Castellazzi M, Cervellati C, Manfrinato MC, Tamborino C, Hanau S, Volta CA, Baldi E, Kostic V, Drulovic J, Granieri E, Dallocchio F, Bellini T, Dujmovic I, Fainardi E.

Dis Markers. 2016;2016:3672353. doi: 10.1155/2016/3672353. Epub 2016 Jul 31.

36.

The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Dackovic J, Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Martinovic V, Drulovic J.

Neurol Sci. 2016 Sep;37(9):1475-81. doi: 10.1007/s10072-016-2610-1. Epub 2016 May 20.

PMID:
27207679
37.

Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.

Nedeljkovic U, Dackovic J, Tepavcevic DK, Basuroski ID, Mesaros S, Pekmezovic T, Drulovic J.

Arch Med Sci. 2016 Apr 1;12(2):380-9. doi: 10.5114/aoms.2015.47289. Epub 2015 Mar 18.

38.

Brain reserve against physical disability progression over 5 years in multiple sclerosis.

Sumowski JF, Rocca MA, Leavitt VM, Meani A, Mesaros S, Drulovic J, Preziosa P, Habeck CG, Filippi M.

Neurology. 2016 May 24;86(21):2006-9. doi: 10.1212/WNL.0000000000002702. Epub 2016 Apr 27.

39.

Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).

Rodic SZ, Knezevic TI, Kisic-Tepavcevic DB, Dackovic JR, Dujmovic I, Pekmezovic TD, Drulovic JS, Konstantinovic LM.

PLoS One. 2016 Jan 15;11(1):e0147042. doi: 10.1371/journal.pone.0147042. eCollection 2016.

40.

Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity.

Nedeljkovic U, Raspopovic ED, Ilic N, Vujadinovic ST, Soldatovic I, Drulovic J.

Acta Neurol Belg. 2016 Sep;116(3):309-15. doi: 10.1007/s13760-015-0563-4. Epub 2015 Nov 12.

PMID:
26563405
41.

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

Bustamante MF, Morcillo-Suárez C, Malhotra S, Rio J, Leyva L, Fernández O, Zettl UK, Killestein J, Brassat D, García-Merino JA, Sánchez AJ, Urcelay E, Alvarez-Lafuente R, Villar LM, Alvarez-Cermeño JC, Farré X, Lechner-Scott J, Vandenbroeck K, Rodríguez-Antigüedad A, Drulovic JS, Martinelli Boneschi F, Chan A, Oksenberg J, Navarro A, Montalban X, Comabella M.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e154. doi: 10.1212/NXI.0000000000000154. eCollection 2015 Oct.

42.

Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.

Milosevic E, Dujmovic I, Markovic M, Mesaros S, Rakocevic G, Drulovic J, Mostarica Stojkovic M, Popadic D.

J Neuroimmunol. 2015 Oct 15;287:64-70. doi: 10.1016/j.jneuroim.2015.07.011. Epub 2015 Aug 12.

PMID:
26439963
43.

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)--Development of an Outcome Instrument for Educational Interventions.

Heesen C, Kasper J, Fischer K, Köpke S, Rahn A, Backhus I, Poettgen J, Vahter L, Drulovic J, Van Nunen A, Beckmann Y, Liethmann K, Giordano A, Fulcher G, Solari A; AutoMS-group.

PLoS One. 2015 Oct 2;10(10):e0138364. doi: 10.1371/journal.pone.0138364. eCollection 2015.

44.

Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.

Kisic-Tepavcevic D, Pekmezovic T, Trajkovic G, Stojsavljevic N, Dujmovic I, Mesaros S, Drulovic J.

J Neurol Sci. 2015 Nov 15;358(1-2):317-23. doi: 10.1016/j.jns.2015.09.023. Epub 2015 Sep 10. Erratum in: J Neurol Sci. 2017 Jan 15;372:201.

PMID:
26384617
45.

Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.

Rocca MA, Preziosa P, Mesaros S, Pagani E, Dackovic J, Stosic-Opincal T, Drulovic J, Filippi M.

Radiology. 2016 Mar;278(3):841-53. doi: 10.1148/radiol.2015150532. Epub 2015 Sep 4.

PMID:
26348234
46.

Are Leber's mitochondial DNA mutations associated with aquaporin-4 autoimmunity?

Dujmovic I, Jancic J, Dobricic V, Jankovic M, Novakovic I, Comabella M, Drulovic J.

Mult Scler. 2016 Mar;22(3):393-4. doi: 10.1177/1352458515590649. Epub 2015 Jul 24. No abstract available.

PMID:
26209590
47.

The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.

Drulovic J, Basic-Kes V, Grgic S, Vojinovic S, Dincic E, Toncev G, Kezic MG, Kisic-Tepavcevic D, Dujmovic I, Mesaros S, Miletic-Drakulic S, Pekmezovic T.

Pain Med. 2015 Aug;16(8):1597-602. doi: 10.1111/pme.12731. Epub 2015 Jun 18.

PMID:
26087108
48.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

49.

Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.

Skundric DS, Cruikshank WW, Drulovic J.

J Neuroinflammation. 2015 Apr 22;12:78. doi: 10.1186/s12974-015-0292-x.

50.

IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis.

Zhang X, Tao Y, Chopra M, Dujmovic-Basuroski I, Jin J, Tang Y, Drulovic J, Markovic-Plese S.

J Immunol. 2015 Jun 1;194(11):5139-49. doi: 10.4049/jimmunol.1401680. Epub 2015 Apr 20.

Supplemental Content

Loading ...
Support Center